Matarin Capital Management, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,303,000
+112.9%
28,453
+133.5%
0.27%
+123.8%
Q2 2020$612,000
-92.7%
12,183
-91.1%
0.12%
-84.8%
Q4 2019$8,415,000
-30.2%
136,217
-32.2%
0.80%
-11.8%
Q3 2019$12,062,000
-32.3%
200,771
-5.0%
0.91%
-28.5%
Q2 2019$17,828,000
-10.9%
211,278
+0.9%
1.28%
-12.4%
Q1 2019$20,002,000
-99.9%
209,403
-0.2%
1.46%
+21.1%
Q4 2018$14,864,738,000
-17.3%
209,865
-0.2%
1.20%
+3.7%
Q3 2018$17,964,376,000
-23.2%
210,208
+4.2%
1.16%
-31.5%
Q2 2018$23,377,378,000
+29.3%
201,703
-9.8%
1.69%
+24.7%
Q1 2018$18,083,952,000
+7.4%
223,507
-22.1%
1.36%
+3.4%
Q4 2017$16,838,636,000
+23.8%
286,957
-1.3%
1.31%
+13.4%
Q3 2017$13,601,063,000
+37.5%
290,621
+5.7%
1.16%
+26.3%
Q2 2017$9,890,650,000
-7.2%
274,893
-20.5%
0.92%
-12.7%
Q1 2017$10,656,061,000
+23.6%
345,976
+34.5%
1.05%
+8.2%
Q4 2016$8,618,478,000
+31.2%
257,268
+4.2%
0.97%
+33.8%
Q3 2016$6,568,626,000
+25.9%
246,848
+4.3%
0.72%
+2.1%
Q2 2016$5,219,015,000
-18.9%
236,690
+8.1%
0.71%
-21.0%
Q1 2016$6,433,088,000
+38.5%
219,036
+55.8%
0.90%
+29.4%
Q4 2015$4,643,570,000
+171.3%
140,629
+197.0%
0.69%
+97.7%
Q3 2015$1,711,410,00047,3550.35%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders